首页> 外文OA文献 >Fentanyl buccal soluble film (FBSF) for breakthrough pain in patients with cancer: a randomized, double-blind, placebo-controlled study

【2h】

Fentanyl buccal soluble film (FBSF) for breakthrough pain in patients with cancer: a randomized, double-blind, placebo-controlled study

机译：芬太尼颊可溶性膜（FBSF）用于治疗癌症患者的突破性疼痛：一项随机，双盲，安慰剂对照研究

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

Background: Fentanyl buccal soluble film (FBSF) has been developed as a treatment of breakthrough pain in opioid-tolerant patients with cancer. The objective of this study was to evaluate the efficacy of FBSF at doses of 200–1200 μg in the management of breakthrough pain in patients with cancer receiving ongoing opioid therapy.

机译：背景：芬太尼颊可溶性膜（FBSF）已被开发为治疗阿片耐受性癌症患者的突破性疼痛的药物。这项研究的目的是评估200–1200μg剂量FBSF对正在接受阿片类药物治疗的癌症患者的突破性疼痛的治疗效果。

著录项

作者
Rauck, R.; North, J.; Gever, L. N.; Tagarro, I.; Finn, A. L.;
展开▼
作者单位

展开▼
年度 2009
总页数
原文格式 PDF
正文语种 {"code":"en","name":"English","id":9}
中图分类

相似文献

外文文献
中文文献
专利

1. Fentanyl buccal soluble film (FBSF) for breakthrough pain in patients with cancer: a randomized, double-blind, placebo-controlled study. [J] . Rauck R, North J, Gever LN, Annals of oncology: official journal of the European Society for Medical Oncology . 2010,第6期

机译：芬太尼颊可溶性膜（FBSF）用于治疗癌症患者的突破性疼痛：一项随机，双盲，安慰剂对照的研究。
2. Fentanyl buccal soluble film (FBSF) for breakthrough pain in patients with cancer: a randomized, double-blind, placebo-controlledn study [J] . A. L. Finn Annals of Oncology . 2010,第6期

机译：芬太尼颊可溶性膜（FBSF）用于治疗癌症患者的突破性疼痛：一项随机，双盲，安慰剂对照的研究
3. A novel 12-week study, with three randomized, double-blind placebo-controlled periods to evaluate fentanyl buccal tablets for the relief of breakthrough pain in opioid-tolerant patients with noncancer-related chronic pain. [J] . Farrar JT, Messina J, Xie F, Pain medicine : . 2010,第9期

机译：一项为期12周的新颖研究，包括三个随机，双盲安慰剂对照期，用于评估芬太尼颊片对阿片耐受性非癌相关性慢性疼痛患者的突破性疼痛的缓解作用。
4. MULTI-CENTER, PLACEBO-CONTROLLED, DOUBLE-BLIND, RANDOMIZED STUDY OF ORAL TOCERANIB PHOSPHATE (PALLADIATM, SU11654), A RECEPTOR TYROSINE KINASE INHIBITOR, FOR THE TREATMENT OF DOGS WITH RECURRENT MAS [C] . Cheryl L London, Carolyn J Henry, Anthony W Rusk, Annual conference of the Veterinary Cancer Society . 2008

机译：多中心，安慰剂对照，双盲，随机研究口服Toceranib磷酸盐（Palladia TM，SU11654），受体酪氨酸激酶抑制剂，用于治疗经常性MAS的狗
5. A Phase II, Randomized, Double-Blind, Placebo-Controlled Trial of Fish Oil (Eicosapentaenoic Acid and Docosahexaenoic Acid) on Lung and Systemic Inflammation in Patients with Acute Lung Injury. [D] . Stapleton, Renee Doney. 2010

机译：鱼油（二十碳五烯酸和二十二碳六烯酸）对急性肺损伤患者的肺和全身炎症的II期，随机，双盲，安慰剂对照试验。
6. Fentanyl buccal soluble film (FBSF) for breakthrough pain in patients with cancer: a randomized double-blind placebo-controlled study [O] . R. Rauck, J. North, L. N. Gever, -1

机译：芬太尼颊可溶性膜（FBSF）用于治疗癌症患者的突破性疼痛：一项随机双盲安慰剂对照研究
7. Absorption and tolerability of fentanyl buccal soluble film (FBSF) in patients with cancer in the presence of oral mucositis [O] . Finn, Andrew L, Hill, WD Charlie, Tagarro, Ignacio, 2011

机译：口腔黏膜炎存在下癌症患者芬太尼颊可溶性膜（FBSF）的吸收和耐受性

Fentanyl buccal soluble film (FBSF) for breakthrough pain in patients with cancer: a randomized, double-blind, placebo-controlled study

摘要

著录项

相似文献

相关主题

期刊订阅